Imagine a world where surgeons can pinpoint the spread of breast cancer with a tool no larger than a pen, eliminating the risks of radioactive exposure or allergic reactions from dyes. This scenario is now a reality with a groundbreaking diamond-based magnetic field sensor developed by researchers
In the fast-evolving landscape of obesity treatment, where pharmaceutical companies race to deliver groundbreaking solutions, Viking Therapeutics emerged with high hopes for their oral weight loss drug, VK2735. Touted as a convenient alternative to injectable therapies dominating the market, this
Amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease that relentlessly attacks motor neurons responsible for muscle movement, has long puzzled scientists and clinicians with its rapid progression and fatal outcomes. A recent study, conducted by a collaborative team from
What happens when the very food meant to nourish us becomes a silent carrier of deadly threats? Each year, an estimated 600 million people worldwide fall ill from foodborne illnesses, with 420,000 losing their lives to pathogens that have grown resistant to traditional defenses, posing a growing
Imagine a world where a diagnosis of multiple myeloma (MM), a devastating blood cancer affecting over 180,000 people globally each year, no longer feels like an insurmountable challenge. With relapse rates stubbornly high and no definitive cure in sight, the urgency for groundbreaking treatments
Welcome to an insightful conversation with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the exciting news surrounding Johnson & Johnson’s recent
